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Abstract Cyclin B is an important regulator of progression
through the cell division cycle. The oscillating appearance of
cyclin B1 and B2 proteins during the cell cycle is in part due to
fluctuating mRNA levels. We had identified earlier a tandem
promoter element named cell cycle-dependent element (CDE)
and cell cycle genes homology region (CHR) which regulates cell
cycle-dependent transcription of cdc25C, cyclin A and cdc2.
Here we describe that cyclin B2 transcription is repressed
through a novel CDE/CHR element in resting and G1 cells. By
relief of this repression in S and G2 oscillating expression of
cyclin B2 mRNA is achieved during the cell cycle. ß 2000
Federation of European Biochemical Societies. Published by
Elsevier Science B.V. All rights reserved.
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1. Introduction
Cyclin B is a central molecule regulating progress through
the cell division cycle. B-type cyclins associate with the cdc2
protein kinase to form the maturation-promoting factor
(MPF) [1^4]. The MPF complex is essential for the transition
from G2 to mitosis [5,6]. The importance of B-type cyclins
was also shown by creating mice with deletions in the genes
for the two identi¢ed mammalian proteins, cyclin B1 and B2.
While knockout mice with deletions in the cyclin B1 gene die
in utero, cyclin B2-null mice are viable. Therefore it seems
that cyclin B1 can compensate for loss of cyclin B2, but not
vice versa. Although cyclin B2 (3/3) mice appear to be nor-
mal they seem to be less fertile and tend to be slightly smaller
[7]. However, when human B-type cyclins are expressed in a
cln3 yeast background cyclin B2 displays a stronger growth-
promoting capability than cyclin B1 [8]. Other results also
suggest distinct roles for the di¡erent forms of cyclin B. It
has been shown that subcellular distribution is dramatically
di¡erent. While cyclin B1 co-localizes with microtubules cyclin
B2 is associated with the Golgi apparatus [9].
One general feature of cyclins is that their protein levels
oscillate during the cell cycle [10]. B-type cyclins appear in S-
phase and accumulate in G2 and mitosis before disappear-
ing at transition from metaphase to anaphase [11]. The
two ways by which these oscillations are maintained are by
regulating synthesis and degradation. In regard to their deg-
radation in recent years great progress has been made in
understanding ubiquitin-mediated proteolysis leading to the
dramatic drop in cyclin B protein levels in the dividing cell
at the metaphase^anaphase transition [11^15].
It has been shown that mammalian cyclin B1 and cyclin B2
are regulated at the transcriptional level during the cell cycle.
Experiments addressing cell cycle-dependent transcription of
cyclin B1 excluded some candidate promoter elements from
being relevant for regulation [16]. Part of the cell cycle-depen-
dent transcriptional regulation might be due to an E-box el-
ement in this promoter [17]. We have cloned the mouse cyclin
B2 promoter and started to analyze its regulation [11,18]. The
mechanism by which cyclin B2 transcription is regulated dur-
ing the cell cycle has still to be elucidated.
Transcriptional regulation during the mammalian cell cycle
has so far been mostly associated with the function of the E2F
family of transcription factors and the retinoblastoma tumor
suppressor protein pRb [19^23]. Heterodimers formed by E2F
and DP components are able to activate transcription of cell
cycle promoters in late G1- and S-phase. In G0 and early G1
complex formation of pRB with E2F/DP represses transcrip-
tion. In a normally dividing cell transition from this repres-
sion in the early phase of the cell cycle to activation at later
times is controlled by phosphorylation of pRb [19^23].
More recently we have identi¢ed another mechanism by
which gene transcription can be regulated in a cell cycle-de-
pendent manner. This mechanism employs a tandem tran-
scriptional element composed of the ‘cell cycle genes homol-
ogy region’ (CHR) and the ‘cell cycle-dependent element’
(CDE). CDE/CHR sites regulate the promoters of cyclin A,
cdc25C and cdc2 genes by repression in G0 and G1 and release
from repression later in the cell cycle [24]. We have described
earlier that the expression of cyclin B2 is largely driven by
activation through three CCAAT promoter elements which
bind NF-Y transcription factors [18]. Here we show that tran-
scription from the cyclin B2 promoter during the cell division
cycle is dependent on a novel CDE/CHR element.
2. Materials and methods
2.1. Cloning and mutation of cyclin B2 promoter luciferase constructs
A genomic DNA fragment was ampli¢ed from a plasmid as tem-
plate which was described earlier [11] with the primers 5P-CGG GGT
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ACC CAA GAA AGA GAA AGC TAT GC-3P and 5P-AGA AGA
TCT GGC CCC GCC GCT CCG CGT C-3P. This created a DNA
segment 369 bp to 31189 bp 5P from the translational start codon of
the mouse cyclin B2 with restriction sites for KpnI and BglII. These
sites were used to clone the fragment into the pGL3 basic vector
(Promega) to create the B2-Luci construct driving the expression of
¢re£y luciferase.
Mutations were introduced by employing the transformer site-di-
rected mutagenesis kit (Clontech) and a primer (5P-CAA TAG TGC
GTC AGC ATT ACG GTA TTT GAA TCG CGG ACC GG-3P) for
mutating the CDE and another oligonucleotide (5P-CAG CGG CGC
GGT ATG CAT ATC GCG GAC CGG GCG GTG G-3P) to change
the CHR. Nucleotide sequences of all constructs were con¢rmed by
sequencing both strands.
2.2. Cell culture and DNA transfection
Omega E mouse ¢broblasts (DSMZ, Braunschweig, Germany) are
derived from NIH3T3 cells. They were cultured in 90% Dulbecco’s
modi¢ed Eagle’s medium (DMEM) supplemented with 10% fetal calf
serum (FCS) at 37‡C in a humidi¢ed atmosphere with 5% CO2. For
transfection 4U104 cells were plated per well in 0.5 ml medium in
24-well plates. Cells were cultured overnight before transfection.
Transfection of cells was done by using 1.5 Wl Pfx-6 (Invitrogen)
with 0.5 Wg plasmid of B2-Luci, its derivatives or a cyclin A construct
and 10 ng of pRL-SV40 (Promega) in 0.25 ml Optimem transfection
medium (Gibco) per well. The cyclin A reporter construct PALUC
was described by Henglein et al. [25]. For transfection, cells were
incubated for 5 h before replacing transfection medium with
DMEM containing 10% FCS. Cells were cultured for 1 day in this
medium. For cell cycle analyses cells were then starved in DMEM
with 0.2% FCS for 60 h. At this time cells were harvested for 0 h time
points. To analyze cells during their passage through the cell cycle the
remaining mouse ¢broblasts were stimulated with 20% FCS in
DMEM for the given times.
2.3. Luciferase assays and FACS analyses
Two kinds of luciferase activities were determined with the dual
luciferase assay (Promega), ¢re£y luciferase and luciferase from Re-
nilla reniformis. Luciferase activities were normalized by comparing
¢re£y luciferase with Renilla luciferase activities expressed from the
pRL-SV40 (Promega) cotransfected control plasmids in a Turner De-
sign TD 20/20 luminometer. Averages of 12 assays were included in
the cell cycle experiments for each point and standard deviations
derived. Stimulation factors for each construct were calculated by
dividing maximal luciferase activities after serum stimulation by val-
ues before addition of serum. Deregulation is the change of the stim-
ulation factor in the mutants versus the stimulation of expression
from the wild-type cyclin B2 plasmid.
Fixation of cells and propidium iodide staining was performed ac-
cording to a published procedure [26]. Cell sorting was done on a
FACScan analyzer with the CELLQuest and ModFit programs (Bec-
ton Dickinson).
3. Results and discussion
3.1. Cell cycle-dependent transcription from a cyclin B2
promoter construct
A genomic DNA fragment covering a region of 1.1 kb up-
stream of the coding region in the mouse cyclin B2 gene,
originally identi¢ed by us [11], was cloned into a luciferase
expressing reporter plasmid resulting in the B2-Luci construct.
Sequencing of the cyclin B2 fragment and comparison with
known transcriptional elements revealed three CCAAT con-
sensus boxes spaced at a distance of 33 bp from each other
(Fig. 1). Two transcriptional start sites have been mapped
[11]. The genomic fragment does not contain any obvious
TATA consensus element (Fig. 1).
In transient transfection assays the cyclin B2 promoter in
B2-Luci confers regulation like the chromosomal gene [11,27].
No signi¢cant transcription is observed in G0 and G1 cells.
Expression starts in S-phase and increases into G2 before
dropping again (Fig. 2A and Table 1). Also timing during
the cell cycle relative to cyclin A appears consistent with pre-
vious observations. Comparison of the expression of B2-Luci
to the luciferase activity from a cyclin A reporter shows that
the two reporters behave like their cellular gene counterparts
(Fig. 2A and B) [11,27].
3.2. CDE and CHR elements are regulating cyclin B2 cell
cycle-dependent transcription
The cyclin B2 promoter carries a number of elements po-
tentially relevant for cell cycle-dependent transcription. We
mutated some of these elements on the basis of the B2-Luci
construct and found their regulation essentially unchanged
compared to the wild-type construct (data not shown). Fur-
ther inspection of the sequence in the 5P-region of the cyclin
B2 gene revealed ¢ve sequences identical to the consensus se-
quence 5P-TTGAA-3P (Fig. 1) which we had earlier identi¢ed
as a CHR element in the cdc2, cyclin A and cdc25C promoters
[24]. There is only one potential CHR element that is located
downstream from a DNA segment that displays some simi-
Fig. 1. Nucleotide sequence of the mouse cyclin B2 promoter. Numbering is relative to the translational start codon. The elements responsible
for activation through NF-Y transcription factors are printed in bold. Two transcriptional start sites are indicated by arrows. Two elements
which display some homology to cell cycle-dependent elements (CDE) and the cell cycle genes homology region (CHR) are boxed.
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larity to CDE sites which are also required to form a func-
tional CDE/CHR repressor element (Fig. 1).
We tested the function of the two putative cell cycle ele-
ments in transfection assays after mutating each half of the
tandem site separately. Both mutations lead to a deregulation
of cell cycle-dependent transcription (Fig. 3 and Table 1). This
shows that cell cycle-dependent transcription of cyclin B2 is
contingent upon intact CDE and CHR elements in its pro-
moter. Stimulation of activity for the wild-type cyclin B2 con-
struct comparing resting and G2 cells is about 68-fold in the
experiment shown. By mutation of the CDE or the CHR this
factor is reduced to 14- or 4.5-fold, respectively. From these
results factors for deregulation of the mutants can be calcu-
lated as about 5-fold for the CDE mutant and 15-fold for the
CHR mutant (Fig. 3B). This indicates that the CHR has a
higher impact than the CDE on the cell cycle-dependent reg-
ulation of the cyclin B2 promoter and that the CDE and CHR
elements are responsible for most of the cell cycle-dependent
transcription. Comparing the transcriptional activity in resting
and in G2 cells the remaining regulation in the CHR mutant is
only similar to that of the SV40 promoter which served as a
control (Fig. 3A). The observation that such cell cycle-depen-
dent regulation is not completely lost has been made earlier
and could be due to a rise in general transcriptional activity
during the cell cycle [24].
At the end of the cell cycle both mutant constructs show
similar activities compared to the wild-type cyclin B2 pro-
moter. To normalize for transfection e⁄ciency we calculated
ratios of luciferase activities from relative light units of ¢re£y
luciferase expressed from cyclin B2 plasmids and light units of
Renilla luciferase transcribed from an SV40-driven control
plasmid. The ratios at 26 h were 0.26, 0.21 and 0.39 for B2-
Luci, B2-CDE-mut and B2-CHR-mut, respectively. Thus, the
three cyclin B2 constructs are expressed at a similar level at
G2/M. The two mutant reporters are already expressed at
signi¢cant levels in resting cells whereas in G0 the wild-type
cyclin B2 plasmid drives expression only at the detection limit
(Fig. 3A). Therefore, maximal activities reached are not af-
fected by the mutations and activator elements do not seem to
be compromised in the mutant plasmids. This indicates that
deregulation is due to a release of repression instead of a
decrease in activation, which is similar to results with other
promoters [24]. Furthermore this is consistent with our obser-
vation that most of the transcriptional activation originates
from three CCAAT boxes in the cyclin B2 promoter activated
by binding the transcription factor NF-Y [18]. For the p130
gene Claude Sardet’s group recently described that promoter
activity in respective CDE/CHR mutants does not change
signi¢cantly during the cell cycle but displays clear activation
of basal activity [28]. In this promoter the distance between
CDE and CHR is di¡erent to that in cyclin B2. We suggest
that there are di¡erent types of CDE/CHR tandem elements
and that the one in cyclin B2 belongs to the ‘classical type’
which confers cell cycle-dependent transcription (Fig. 4). A
detailed de¢nition of the di¡erent types of elements will
only be possible once we identify the protein complexes and
mechanisms regulating through these elements.
3.3. A simian virus 40 promoter-driven control reporter is itself
cell cycle regulated
A reporter driven by an SV40 promoter expressing lucifer-
ase from Renilla is often used to standardize experiments with
cell cycle-regulated promoters. We ¢nd that this standard is
itself in£uenced during the cell cycle. Renilla luciferase expres-
sion from the SV40 promoter is upregulated under the exper-
imental conditions about 5-fold during the cell cycle compar-
ing values from resting cells versus cells with maximum
expression in S/G2 (Figs. 2 and 3A). The degree of this up-
regulation very much depends on the culture density of plated
Fig. 2. Expression of luciferase reporter constructs during the cell
cycle in resting and restimulated NIH3T3-derived Omega E mouse
¢broblasts. Cells were cultured 24 h after transfection and serum
starved for 60 h before restimulation. Time after restimulation is in-
dicated. Activity from ¢re£y luciferase reporter assays is given as
percent of the maximum value. Values are averages of 12 assays per
time point and standard deviations are given. A: Transcription
from the mouse cyclin B2 promoter in the B2-Luci construct. B: cy-
clin A transcriptional activity from the PALUC plasmid.
Table 1
Cell cycle distribution of mouse ¢broblasts examined with DNA
staining followed by FACS analysis
Time (h) G0/G1 (%) S (%) G2/M (%)
0 93.4 6.1 0.5
14 90.6 9.4 0.0
18 44.6 55.5 0.0
20 40.6 52.1 7.4
22 34.6 33.9 31.6
24 66.7 15.8 17.6
26 69.4 23.1 7.6
28 60.9 38.3 0.8
30 61.7 36.4 1.9
Relative cell numbers for di¡erent cell cycle phases are given. DNA
content of mouse ¢broblasts cultured in parallel to cells used in the
experiment for Figs. 2 and 3 were analyzed by FACS. Cells were
transfected and treated the same way as cells used for Figs. 2 and
3. They were harvested at the same time points. Cells were DNA
stained with propidium iodide and FACS analyzed. Relative cell
numbers giving the distribution of cells in various cell cycle phases
were obtained with the ModFit analysis software.
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cells. Similar results with even stronger regulation were ob-
tained with a cytomegalovirus promoter (data not shown).
3.4. The cyclin B2 promoter is regulated by a novel CDE/CHR
element
A comparison of the CDE in cyclin B2 reveals that it is
di¡erent from known CDE and E2F elements (Fig. 4). E2F
and CDF-1, a protein whose molecular identity has not yet
been unveiled, have so far been implicated in regulating
through the CDE in the cdc25C, cyclin A and cdc2 promoters
[24,29]. We have not observed any complex with cdc25C
CDE/CHR oligonucleotides in EMSAs that could also bind
to a cyclin B2 probe (data not shown). In order to test a
potential involvement of E2F in activating cyclin B2 transcrip-
tion we cotransfected E2F-1 and DP-1 expressing plasmids
together with reporter constructs. In these experiments the
cyclin B2 promoter remained una¡ected by E2F while an
E2F-responsive promoter was strongly stimulated (data not
shown).
We have shown that cell cycle-dependent expression of the
cyclin B2 promoter results from counteracting the activation
by NF-Y through repression by a CDE/CHR tandem element
in resting cells and the beginning of the cell cycle. Relief of
this repression later during the cell cycle allows the accurate
expression of the cyclin B2 protein to form MPF by complex-
ing with the kinase cdc2 and controlling transition from G2 to
mitosis. Future experiments are aimed at identifying the pro-
tein components involved in cell cycle-dependent transcrip-
tional regulation through the CDE/CHR.
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Fig. 3. Deregulation of cyclin B2 transcription by mutation in the CDE and CHR elements. A: Comparison of activities from cyclin B2 wild-
type and mutant promoter constructs between quiescent and serum stimulated cells. In all experiments mouse ¢broblast cells were transiently
transfected with B2-Luci (cyclin B2 wild-type), B2-CDE-mut or B2-CHR-mut plasmids driving expression of ¢re£y luciferase. Cells were co-
transfected with a simian virus 40 promoter-driven construct which regulates expression of Renilla luciferase. After transfection cells were serum
starved for 60 h. At this time cells for the 0 h time point were harvested. Later times refer to cultures analyzed after restimulation with FCS
for the respective times. The ratios of activities from ¢re£y cyclin B2 reporters and the Renilla SV40-driven controls at 26 h were 0.26, 0.21
and 0.39 for B2-Luci, B2-CDE-mut and B2-CHR-mut, respectively. The maximal expression for each plasmid was set at 100%. All other activ-
ities are given relative to this value. Averages from 12 assays with standard deviations are presented. B: Stimulation factors for each construct
were calculated by dividing maximal luciferase activities after serum stimulation by values before addition of serum. Deregulation is the change
of the stimulation factor in the mutants versus the stimulation of expression from the wild-type cyclin B2 plasmid. Experiments shown in Fig.
2 and this ¢gure were done in parallel and results for the wild-type cyclin B2 construct represent the same assays.
Fig. 4. Alignment of regulatory elements of cell cycle-regulated pro-
moters. Cell cycle-dependent transcription of cyclin B2, cyclin A,
cdc2 and cdc25C is regulated by the ‘classical type’ CDE and CHR
tandem elements. The B-myb gene expression is dependent on an
E2F site in conjunction with a CHR element (or downstream re-
pression site, DRS). DNA segments of the genes for mouse cyclin
B2 and human cyclin A, cdc25C, and cdc2, and mouse B-myb are
shown [24,30^33].
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